Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-l-phosphate

被引:131
作者
Siess, W [1 ]
机构
[1] Univ Munich, Fac Med, Inst Prevent Cardiovasc Dis, D-80336 Munich, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS | 2002年 / 1582卷 / 1-3期
关键词
lysophosphatidic acid; sphingosine-1-phosphate; atherosclerosis; thrombosis; vascular tone; plaque stability; endothelial dysfunction; neointima; platelet activation;
D O I
10.1016/S1388-1981(02)00173-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lysophosphatidic acid (LPA) and sphingosine-1-phosphate (SIP) are potent bioactive phospholipids with specific and multiple effects on blood cells and cells of the vessel wall. Released by activated platelets, LPA and S1P mediate physiological wound healing processes such as vascular repair. Evidence is accumulating that these lipid mediators can, however, under certain conditions become athero- and thrombogenic molecules that might aggravate cardiovascular disease. For example, LPA present in minimally modified LDL and within the intima of atherosclerotic lesions may play a role in the early phase of atherosclerosis by inducing barrier dysfunction and increased monocyte adhesion of the endothelium, as well as in the late phase by triggering platelet activation and intra-arterial thrombus formation upon rupture of the atherosclerotic plaque. Moreover, LPA and S1P, by stimulating the proliferation of fibroblasts and by enhancing the survival of inflammatory cells are likely to play a central role in the excessive fibroproliferative and inflammatory response to vascular injury that characterizes the progression of atherosclerosis. Furthermore, LPA can cause the phenotypic dedifferentiation of medial vascular smooth muscle cells, and S1P is able to stimulate the migration and proliferation of intimal vascular smooth muscle cells; both processes ultimately lead to the formation of the neointima. Most importantly, as LPA and S1P bind to and activate multiple G-protein receptors, it emerges that the beneficial or harmful action of LPA and S1P are critically dependent on the expression profile of their receptor subtypes and their coupling to different signal transduction pathways in the target cells. By targeting specific subtypes of LPA and S1P receptors in selective cells of the vascular wall and blood, new strategies for the prevention and therapy of cardiovascular diseases can be envisioned. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:204 / 215
页数:12
相关论文
共 161 条
  • [61] Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells
    Kimura, T
    Sato, K
    Kuwabara, A
    Tomura, H
    Ishiwara, M
    Kobayashi, I
    Ui, M
    Okajima, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) : 31780 - 31785
  • [62] Sphingosine 1-phosphate stimulates proliferation and migration of human endothelial cells possibly through the lipid receptors, Edg-1 and Edg-3
    Kimura, T
    Watanabe, T
    Sato, K
    Kon, J
    Tomura, H
    Tamama, K
    Kuwabara, A
    Kanda, T
    Kobayashi, I
    Ohta, H
    Ul, M
    Okajima, F
    [J]. BIOCHEMICAL JOURNAL, 2000, 348 (pt 1) : 71 - 76
  • [63] Endothelial function and coronary artery disease
    Kinlay, S
    Libby, P
    Ganz, P
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (04) : 383 - 389
  • [64] Activation of G12/G13 results in shape change and Rho/Rho-kinase-mediated myosin light chain phosphorylation in mouse platelets
    Klages, B
    Brandt, U
    Simon, MI
    Schultz, G
    Offermanns, S
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (04) : 745 - 754
  • [65] Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration
    Kluk, MJ
    Hla, T
    [J]. CIRCULATION RESEARCH, 2001, 89 (06) : 496 - 502
  • [66] Lysophosphatidic acid is a major serum noncytokine survival factor for murine macrophages which acts via the phosphatidylinositol 3-kinase signaling pathway
    Koh, JS
    Lieberthal, W
    Heydrick, S
    Levine, JS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (04) : 716 - 727
  • [67] Res-MAP kinase signaling by lysophosphatidic acid and other G protein-coupled receptor agonists
    Kranenburg, O
    Moolenaar, WH
    [J]. ONCOGENE, 2001, 20 (13) : 1540 - 1546
  • [68] Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production
    Kwon, YG
    Min, JK
    Kim, KM
    Lee, DJ
    Billiar, TR
    Kim, YM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) : 10627 - 10633
  • [69] Lysophosphatidic acid promotes phorbol-ester-induced apoptosis in TF-1 cells by interfering with adhesion
    Lai, JM
    Lu, CY
    Yang-Yen, HF
    Chang, ZF
    [J]. BIOCHEMICAL JOURNAL, 2001, 359 (01) : 227 - 233
  • [70] Membrane sidedness of biosynthetic pathways involved in the production of lysophosphatidic acid
    Le Balle, F
    Simon, MF
    Meijer, S
    Fourcade, O
    Chap, H
    [J]. ADVANCES IN ENZYME REGULATION, VOL 39, 1999, 39 : 275 - 284